Macitentan in Combo With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
 
Sponsors and Collaborators
Actelion
 
Contact
Charles Conrad, MD
MD Anderson Cancer Center
713-792-2883
 
ClinicalTrials.gov Identifier

NCT01499251

 


Continue Reading